Cargando…
Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study
Despite the success of arsenic trioxide (ATO) in treating haematological malignancies, its potential to treat solid tumours has not been fully exploited, owing to its dose-limiting toxicity and poor pharmacokinetics. In order to overcome this hurdle, liposomal encapsulation of the drug with differen...
Autores principales: | Akhtar, Anam, Wang, Scarlet Xiaoyan, Ghali, Lucy, Bell, Celia, Wen, Xuesong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979440/ https://www.ncbi.nlm.nih.gov/pubmed/29617346 http://dx.doi.org/10.3390/ijms19041081 |
Ejemplares similares
-
Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro
por: Akhtar, Anam, et al.
Publicado: (2019) -
Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers
por: Akhtar, Anam, et al.
Publicado: (2017) -
Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology
por: Wang, Xiaoyan, et al.
Publicado: (2016) -
Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020) -
Liposome-delivered baicalein induction of myeloid leukemia K562 cell death via reactive oxygen species generation
por: Wang, Scarlet Xiaoyan, et al.
Publicado: (2018)